5例非小细胞肺癌G719X突变临床特征及治疗疗效_房延凤.pdfVIP

  • 1
  • 0
  • 约3.39万字
  • 约 4页
  • 2025-06-14 发布于北京
  • 举报

5例非小细胞肺癌G719X突变临床特征及治疗疗效_房延凤.pdf

18·84·,5G719X

房延凤等例非小细胞肺癌突变临床特征及治疗疗效

[13],.UCH37ringEGFRmutation:resultsofthenationwideFrenchCooperative

王川丽王俊峰与非小细胞肺癌患者预后的相关性

[J].,2019,29(5)

研究中国现代医学杂志:35-39.ThoracicIntergroup(IFCT)program[J].AnnOncol,2017,28

WANGCL,WANGJF.CorrelationbetweenUCH37andprognosis(11):2715-2724.

inpatientswithnon-small-celllungcarcinomasyndrome[J].[17],.CEA、SCCA、CYFRA21-1

方高洁胡娟肿瘤标记物联合

ChineseJournalofModernMedicine,2019,29(5):35-39.NSE检测对肺癌的诊断价值分析[J].实用癌症杂志,2019,

34(7)

[14]LOUW,CHENY,ZHUKY,etal.PolyphyllinIovercomesEMT:1161-1163,1175.

-associatedresistancetoerlotinibinlungcancercellsviaIL-6/FANGGJ,HUJ.DetectionvalueoftumormarkersCEA、SCCA、

STAT3pathwayinhibition[J].BiolPharmBull,2017,40(8):CYFRA21-1combinedwithNSEforlungcancer[J].ThePrac-

1306-1313.ticalJournalofCancer,2019,34(7):1161-1163,1175.

[15]SIL,TIANH,YUEW,etal.PotentialuseofmicroRNA-200cas[18]SONGH,LIUS,ZHAOZ,etal.IncreasedcyclesofDC/CIKim-

aprognosticmarkerinnon-smallcelllungcancer[J].OncolmunotherapydecreasesfrequencyofTregsinpatientswit

文档评论(0)

1亿VIP精品文档

相关文档